These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34181144)

  • 1. Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report.
    Özkan G; Bayrakçı N; Karabağ S; Güzel EÇ; Ulusoy S
    Int Urol Nephrol; 2022 Apr; 54(4):971-972. PubMed ID: 34181144
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination.
    Sriwijitalai W; Wiwanitkit V
    Int Urol Nephrol; 2022 Dec; 54(12):3299. PubMed ID: 35727465
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimal change disease relapse following SARS-CoV-2 mRNA vaccine.
    Kervella D; Jacquemont L; Chapelet-Debout A; Deltombe C; Ville S
    Kidney Int; 2021 Aug; 100(2):457-458. PubMed ID: 33964312
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter regarding "Minimal change disease relapse following SARS-CoV-2 mRNA vaccine".
    Schwotzer N; Kissling S; Fakhouri F
    Kidney Int; 2021 Aug; 100(2):458-459. PubMed ID: 34052236
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Komaba H; Wada T; Fukagawa M
    Am J Kidney Dis; 2021 Sep; 78(3):469-470. PubMed ID: 34023417
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
    Hartley JL; Bailey N; Sharma A; Shawki H
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
    Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
    Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M
    Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824
    [No Abstract]   [Full Text] [Related]  

  • 9. [A possible relationship between anti-SARS-CoV-2 vaccination and glomerular diseases: food for thought for the nephrologist].
    Rizzo M; Marino A; Sannino A; Urciuoli V; Capuano I; Pisani A
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal change disease following the Moderna COVID-19 vaccine: first case report.
    Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM
    BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
    Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal change disease following vaccination for SARS-CoV-2.
    Mancianti N; Guarnieri A; Tripodi S; Salvo DP; Garosi G
    J Nephrol; 2021 Aug; 34(4):1039-1040. PubMed ID: 34143368
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination.
    Jongvilaikasem P; Rianthavorn P
    Pediatr Nephrol; 2022 Jun; 37(6):1419-1421. PubMed ID: 35132446
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination.
    Aydın MF; Yıldız A; Oruç A; Sezen M; Dilek K; Güllülü M; Yavuz M; Ersoy A
    Kidney Int; 2021 Aug; 100(2):464-465. PubMed ID: 33992674
    [No Abstract]   [Full Text] [Related]  

  • 15. Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine.
    Morlidge C; El-Kateb S; Jeevaratnam P; Thompson B
    Kidney Int; 2021 Aug; 100(2):459. PubMed ID: 34119512
    [No Abstract]   [Full Text] [Related]  

  • 16. An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Maas RJ; Gianotten S; van der Meijden WAG
    Am J Kidney Dis; 2021 Aug; 78(2):312. PubMed ID: 33992727
    [No Abstract]   [Full Text] [Related]  

  • 17. Relapse of Idiopathic Nephrotic Syndrome After SARS-CoV-2 Vaccination: Two Case Reports.
    Güngör T; Yazılıtaş F; Kargın Çakıcı E; Karakaya D; Bülbül M
    J Paediatr Child Health; 2022 May; 58(5):939-940. PubMed ID: 35416332
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
    Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
    Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surprising course of multiple sclerosis relapse in a patient after SARS-CoV-2 vaccination.
    Łagosz P; Biegus J; Gruszka E; Zymliński R
    Kardiol Pol; 2022; 80(2):237-238. PubMed ID: 35014011
    [No Abstract]   [Full Text] [Related]  

  • 20. Report of two cases of minimal change disease following vaccination for COVID -19.
    Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
    Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.